Skip to content Skip to sidebar Skip to footer

Decoding the CDC’s Annual Report: Significant Declines in Healthcare-Associated Infections

The Centers for Disease Control and Prevention (CDC) have recently published their annual progress report on healthcare-associated infections on January 29th. The report indicates substantial decreases in hospital-related infections in the year gone by. The salient findings of the report include a significant 11% decrease in hospital-onset Clostridioides difficile, commonly known as C. difficile, infection.…

Read more

Pioneering a Global Fight Against Superbugs: B.C. Researchers Streamline Whole-Genome Research on C. difficile

Dr. Michael Trimble, in collaboration with several other scientists, is spearheading a breakthrough research project focused on whole-genome sequencing. This project, launched by Fraser Health and Simon Fraser University (SFU), is poised to transform the way researchers and healthcare professionals combat superbugs - microscopic organisms resistant to most medications, rendering them particularly challenging to manage.…

Read more

Utilizing Hand-Hygiene Measures in Intensive Care Units to Ward Off C. difficile: A Successful Case Study

A prime essential in healthcare delivery, infection prevention, took a significant stride towards progress at a tertiary rehabilitation Intensive Care Unit (ICU) in the Upper Midwest areas of the United States. They turned the tide against an upsurge in C. difficile infections through an all-encompassing infection prevention initiative, as reported at IDWeek 2025 in Atlanta,…

Read more

LPOXY Therapeutics Secures Funding for Innovative Approach to Preventing C. difficile Infections

LPOXY Therapeutics, a pioneering biopharmaceutical corporation in the clinical development phase, is making notable strides in developing a preventive method for Clostridioides difficile infections that does not involve antibiotics. The company recently signed an agreement with 5Horizons Ventures, a recognized venture capital firm specializing in life sciences, with a proven track record of supporting revolutionary…

Read more

Implementing Electronic Hand Hygiene Systems to Improve Infection Control in Hospitals

Clostridioides difficile (C. diff) is a healthcare-associated infection causing significant morbidity, mortality, and financial strain in American healthcare, despite rigorous infection prevention programs. The resilience of its spores to alcohol-based hand sanitizers makes soap and water washing a necessity for hospital staff. However, achieving perfect compliance with hygiene guidelines is a challenge, particularly when managing…

Read more

Optimizing Infection Control: The Role of Genomic Analysis in Managing Toxin-Producing C. diff. Transmission

In the healthcare industry, promoting wellness is a team effort that pays significant attention to infection control. The image of a bustling hospital ward, with dedicated healthcare personnel diligently checking on patients, casts a striking illustration of the centrality of infection control in patient wellbeing. One particular culprit, the toxin-producing Clostridioides difficile, has been flagged…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]